Substance abuse, in particular when it comes to prescription drugs, is on the rise across the United States, with an estimated 15 million Americans being addicted to prescription medicine – more than the total number of heroin, cocaine, and hallucinogens users combined. Known as a spring-break destination and a state of heavy drinking, with about 58 percent of people being regular drinkers, Florida also has a serious substance abuse problem, with almost 3,000 drug-induced deaths reported in the state on an annual basis. Organizations such as Ethema Health Corporation (OTCQB: GRST) are working hard to tackle the negative effects of addiction on the local population by offering some of the most innovative and comprehensive substance abuse treatments available across the state.

According to statistics from DrugRehab.com, almost half of people addicted to heroin and opioids in Florida are aged 30 and under, while more than 3,000 of the patients admitted to rehabilitation in 2015 statewide were under 18 years of age (roughly 10.6 percent of the total number of people who sought treatment for their addiction problem). In addition, Florida prescribes up to 10 times more oxycodone than all the other states combined and has one of the highest rates of overdose deaths in the country, according to the Addiction Blog (http://dtn.fm/PF6mi).

The startling figures explain why Florida is also a known center for rehabilitation facilities. Often referred to as the rehab capital of America, Delray Beach is home to multiple addiction centers, including Ethema Health Corporation’s Seastone Drug Rehabilitation and Alcohol Treatment Center. Opened in 2012, the facility’s comprehensive, holistic approach to substance abuse treatment and recovery has quickly positioned it as a leader in a highly competitive market, as well as a center focused on getting long-lasting results and the complete recovery of its clients.

The company’s unique approach revolves around the concept of treating not only the addiction but also any underlying disorders that enabled the substance abuse in the first place. Additionally, the center focuses on providing only highly customized and individualized treatment options, designed to ensure that each and every client gets a treatment plan tailored to their specific needs and problems.

Multiple treatment programs are available at the facility, ranging from drug addiction education and psychiatric evaluation to individual and group therapy, eye movement desensitization and reprocessing, yoga and art therapy, and more. All the treatments are results oriented and focused on the concept of inclusion, which means that throughout their rehabilitation process all clients receive core team support in the form of family or friends. The treatment plans available at the facility are designed to aid clients throughout their entire journey to recovery, from understanding and accepting their addiction problem to developing the necessary skills to live their lives after leaving rehab.

Ethema’s client-focused, non-judgmental approach is making the company a major provider of quality addiction treatment services in Florida. The company’s professionalism has also been acknowledged by the Joint Commission on Accreditation of Healthcare Organizations, which has granted Seastone its Gold Seal of Approval®.

For more information about Ethema Health Corporation and Seastone, visit www.seastonedrugrehab.com

Let us hear your thoughts: Ethema Health Corporation Message Board

ChineseInvestors.com, Inc. (OTCQB: CIIX) is projected to reach revenues of $14.8 million by fiscal year 2020, according to a new research report by Consilium Global Research (http://dtn.fm/d849H). Per the report, the company did $930,000 in revenue for fiscal 2016 and is projected to grow at a compound annual growth rate (CAGR) of approximately 100% through 2020. The underlying market’s CAGR will expand at an 80% rate, the report said. Consilium sees CIIX as going through a huge transformation this year as it pursues a larger stake in the cannabis market.

Headquartered in San Gabriel, California, CIIX offers a range of consulting services and educational tools for Chinese investors, but, most recently, it has been pursuing a presence in the growing cannabidiol (CBD) market. In line with these efforts, the company opened the first online CBD store in the Chinese language in the free trade area of Shanghai. It seeks to serve some 1.4 billion people. The site will sell hemp-based food and beverages and hemp-derived CBD. It seeks to sell, where legal, to Chinese-speaking consumers worldwide through its online store, www.ChineseCBDoil.com.

Consilium, an independent research company, notes in its report that the CBD industry is anticipated to grow to $2.1 billion by 2020, representing a CAGR of 80%. The research firm goes on to forecast that the sales of $14.8 million by FY2020 predicted for CIIX is achievable due to the company management’s ability to execute. In fact, Consilium feels that its projections could easily prove conservative. It also estimated that CIIX could reach sales of $1.86 million in FY2017, $3.7 million in FY2018 and $7.4 million in FY2019. CIIX reported revenues of $930,000 in FY2016. For the nine months ended February 28, 2017, it reported revenues of $1.35 million.

Consilium believes that CIIX has a strong management team that has entrepreneurial skills and vision. It also finds that the firm is engrained with Chinese speakers in both the U.S. and abroad. Weaknesses are that it may have to raise more money to compete. It will also need to have sufficient and appropriate resources to stay abreast of evolving requirements for legality in the U.S. and abroad, per the research report.

With no impediments cited by the report in terms of brand leaders, laws, or standouts in this nascent market, Consilium sees opportunities for growth for CIIX. These include strategic international expansion, the large size of the Chinese market and the successful leverage of the legal cannabis market, which Consilium anticipates will drive growth for years to come.

For more information, visit the company’s website at www.ChineseInvestors.com

Let us hear your thoughts: ChineseInvestors.com, Inc. Message Board

The Job Openings and Labor Turnover Summary (JOLTS) released on Tuesday May 9, 2017, by the Bureau of Labor Statistics (BLS) shows that ProBility Media Corp. (OTCQB: PBYA) has got its ducks lined up in a row. The JOLTS proclaimed happy tidings: the number of manufacturing jobs added in March was the highest for any month since ‘the front end of the Great Recession in early 2008’, according to U.S. News (http://dtn.fm/ORz1Z). But this good news was bundled with some bad news. America is experiencing a skills gap: a mismatch between the skills employers require and the skills the workforce possesses. ProBility Media Corp., however, is aiming to narrow that gap. With its suite of technical training and testing solutions, the company is empowering America’s craftsmen and skilled workers once again.

The JOLTS report (http://dtn.fm/vM5mu) revealed that, in March, manufacturing industries added 322,000 to their payrolls. This brings to 922,000 the number of manufacturing hires for the first quarter of 2017, an 11 percent year-over-year increase on 2016. The report also showed that there were 394,000 job openings at the end of March, matching the record highest, attained in July 2016, since April 2006. Manufacturing output has expanded substantially since the doldrums of the financial crisis in 2009, with the St. Louis Fed’s index of real manufacturing output recording a rise of 29 percent. Contrary to widespread reports, manufacturing employment has also risen since the Great Depression, although less than output. FRED (Federal Reserve Economic Data) shows employment in the sector rising by 8 percent, from 11,475,000 in December 2009 to 12,396,000 in April 2017 (http://dtn.fm/3XnsM).

While the data provides some reassurance that American manufacturing is alive and well, it also reveals a disturbing trend of layoffs, which signals a skills gap. In March, some 105,000 manufacturing workers were laid off. Factories are hiring, but they’re firing, too.

However, ProBility is endeavoring to fill that skills gap. The company provides a range of education and training programs for a wide variety of vocational occupations such as craning, rigging, electrical, plumbing and HVAC.

ProBility is disrupting the technical vocations training and certification industry by creating the first full service training and career advancement brand in the technical fields. It has undertaken a major push into the crane training space and is now developing online training programs employing virtual reality technology. ProBility’s crane e-learning products include full crane operator’s courses that simulate the hands-on experience of a lab and physical school. In addition, its publishing division has been working to create full handbooks to accompany the online courses.

ProBility continues to expand its suite of e-learning, training and testing services, through both acquisitions and internal growth. The company is positioning itself as the go-to resource for individuals, small- and medium-size businesses, and large enterprise customers by offering consistent high-quality training services and materials for education, testing, and career advancement.

For more information, visit the company’s website at www.ProBilityMedia.com

Let us hear your thoughts: ProBility Media Corp. Message Board

The transactional process of paying for goods and services has changed radically over the last couple decades. Not that long ago, cash registers and tellers were the only point of sale system in existence. Tellers had to manually enter each product cost, total the sale, take the money, place it in the cash drawer, then hand the customer a paper receipt. The only transaction record a business would have would be their own copy of the paper till roll.

Point of sale systems evolved with computerization and eventually stored product price data on the register itself or on an attached computer. Newer POS systems included a barcode reader, which eliminated the need for manual price entry, and transaction details were stored electronically. Transactional processes have become ever more sophisticated over the last dozen years. Modern POS systems now integrate with other electronic systems and databases, which means that a day’s transactions can be immediately reconciled with accounting and inventory management systems. Add in mPOS (mobile point of sale) and businesses now have the ability to take card payments from anywhere in the world with a network connection making point of sale fast, reliable, convenient, secure and truly portable.

Paying for transactions with mobile devices (mPOS) has proved mutually beneficial for both consumers and merchants. Consumers find it easier to ditch credit cards all together and rely on their mobile devices to make payments. Mobile point-of-sale transactions give merchants the ability to integrate loyalty and incentive programs into mobile payment applications, track customer trends and inventory, increase check-out speed and save money on credit card fees. An estimated $37 billion in mobile transactions occurred in 2015, and that total is expected to explode to over $800 billion by 2019. Net Element (NASDAQ: NETE) is at the forefront of facilitating this mPOS boom.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group. TOT Group companies include Aptito, Digital Provider, Restoactive, PayOnline and Unified Payments, which was named the fastest-growing private company in America in 2012 by Inc. Magazine. Through its wholly owned group of companies, Net Element delivers tailored turnkey solutions that fit each merchant’s specific needs. The company’s online and offline payment capabilities allow merchants to transact business anywhere, any way and at any time. Simultaneously, Net Element’s mobile payments and value-added transactional platforms deliver speed and convenience to mobile customers, giving them the ability to conveniently make secure purchases with just a few clicks on their mobile devices.

It’s a long way since checkout tellers manually tapped prices into cash registers. Small businesses now access and utilize functionality that even large retailers could have only dreamed about 20 years ago, and consumers are embracing the speed and convenience of mPOS. Providing state of the art platforms and systems for this new transactional process places Net Element directly in the path of opportunity.

For more information, visit www.NetElement.com

Moxian, Inc. (NASDAQ: MOXC) is projected to have a breakout year in FY 2018, when SeeThruEquity projects it will reach $24.1 million in revenues and a net income of $4.5 million (http://nnw.fm/73aAZ). This performance is expected based on the massive size of the online-to-offline (O2O) market in China, estimated to reach $48 billion in 1H17, according to investor materials provided by Moxian.

The China-based high technology company has offered free beta-platform apps for its 30,000 small and medium-sized enterprise (SME) users on its Moxian+ app. To its 300,000 consumer customers, it offers the Moxian User app with social sites. Now, it is converting to paid Moxian+ and Moxian User apps, changing these free user service sites to paid subscriber status.

But there is more to Moxian’s marketing plan than subscriber conversions from free to paid. The company is also anticipating licensing, OEM, and distribution revenues that will be significant. As SeeThruEquity’s analysis mentions, Moxian may find a challenge converting some of the current no-charge users of its Moxian+ business app and Moxian User consumer apps to paid subscribers, but Moxian hopes to gain transaction fees and subscription revenue from the conversions and is adding sales staff, hoping to also add additional new SME and consumer paid subscribers to its platforms who have not been on the apps in the past.

SeeThruEquity is optimistic about Moxian’s aggressive growth strategy, but added a note of caution, saying, “they must win new customers from scratch, which may be more difficult than anticipated.” Nevertheless, Moxian sees a special revenue stream opportunity in its OEM, distribution, and license fees.

Moxian projects a greater than 163% jump in year-over-year revenue growth from 2017 to 2018. Moxian management sees merchant transactions generating the lead amount of sales in 2017 in the revenue mix at 36.8%. OEM, distribution and license fees were seen as only generating 31.6% by comparison. By 2018, however, the estimated mix changes dramatically. OEM, distribution and license fees are projected to account for 48% of revenues within the mix, doubling the sales of mobile advertisements and towering over the contribution of 28% by merchant transactions. Further, OEM, distribution and license fees projections exhibit a 300% year-over-year growth from 2017 to 2018, from $3 million in 2017 to $12 million in 2018 — tripling the YOY growth of either merchant transactions or mobile advertisements.

Moxian management believes it can achieve cash flow break even by the end of 2017. This is, in part, because the company is anticipating high 70% gross margins on its own direct sales and high margins, too, from mobile advertisements on its sites.

For more information, visit www.Moxian.com

With the passage of the Rohrabacher-Farr amendment in the $1.1 trillion spending bill to fund the government until September 30, 2017, Congress continues its hands-off approach to the medical marijuana industry. Attached as a rider to the appropriations bill, Rohrabacher-Farr now allows marijuana dispensaries powerful ‘safe harbor’ protections. As a consequence, SinglePoint, Inc. (OTC: SING) is rebooting its initiatives, started two years ago, to be a ‘first mover’ in providing payment solutions to the cannabis vertical through its SingleSeed payments subsidiary.

SinglePoint has been working with medical marijuana (MMJ) businesses for a long time, as GeekWire reported in August 2014 (http://dtn.fm/gm9pX). Back then, the company engaged with more than 100 state-licensed dispensaries in Colorado and Washington to set up point-of-sale terminals that would enable patients to pay for their marijuana purchases with debit and credit cards. SinglePoint’s leadership in providing payment solutions to the newly legalized MMJ industry went up in smoke, however, since banks, afraid of falling afoul of the law, refused to process the payments. Federal money transmitting regulations prohibit ‘the transportation or transmission of funds that… have been derived from a criminal offense or are intended to be used to promote or support unlawful activity’.

In this decidedly more benign environment, SinglePoint, through its SingleSeed Payments subsidiary, is offering a novel payment solution to MMJ dispensaries with its cashless ATM that closely resembles the typical debit/credit card terminal. However, unlike traditional terminals that are associated with an identifiable merchant account, the SingleSeed terminal is linked to the ATM network. As a result, a transaction through a SingleSeed cashless ATM, like a cash withdrawal from any ATM, involves only the account holder, his bank and a cash amount… devoid of other transaction details.

SinglePoint is also breaking ground with its Pay-by-Text™ technology, a tool that facilitates both promotional outreach and payments. Pay-by-Text™ offers a swipe-less payment option to customers who install the app on their mobile phones. To make a payment, the purchaser sends a text message to the payment provider, who clears the transaction with the vendor. The cost of the purchase, subsequently, appears on the monthly phone bill. In addition, the Pay-by-Text™ app becomes a marketing tool. Once the customer has set up a Pay-by-Text™ account, the vendor can issue an invitation to receive text messages. With these promotional and payment solutions, SinglePoint is set to capitalize on the opportunities in payments now that federal legislative and judicial action has created a safe harbor for the MMJ industry.

But a lot has changed since then. Now, even though marijuana remains a Schedule 1 substance like ecstasy, heroin and mescaline under the Controlled Substances Act of 1970, 29 states and the District of Columbia have passed resolutions or laws legalizing medical marijuana or regulating its adult use like alcohol or tobacco.

This has prompted a supportive response from the legislative and judicial branches of the federal government, in stark contrast to the mixed messages coming from the executive. Most importantly, the continuation of Rohrabacher-Farr, which prohibits the Justice Department from using funds allocated by Congress to interfere with the implementation of state medical marijuana laws, triggers the ‘safe harbor’ protections of an important court ruling last year.

On August 16, 2016, in United States v. McIntosh, the Ninth Circuit Court of Appeals, the federal appellate court for the states of Alaska, Arizona, California, Hawaii, Idaho, Montana, Nevada, Oregon and Washington, created a ‘safe harbor’ for medical marijuana establishments. Its ruling requires federal district court judges to provide medical marijuana suppliers and users with a pre-trial evidentiary hearing so that they can establish that their activities are compliant with applicable state law. If such compliance is established, then prosecution under the Controlled Substances Act (CSA) should be dismissed or discontinued, as long as Rohrabacher-Farr, which first became law in May 2014, stands. This means that if MMJ dispensaries can demonstrate compliance with state laws by, for example, having a compliance program in place, they cannot be prosecuted under the CSA.

In addition, SinglePoint has announced in a press release (http://dtn.fm/8ErRx) that it has signed an agreement allowing the company to begin offering “high risk” merchant accounts. This is a major step toward providing previously unavailable financial services to companies in high-risk categories, and the company plans to integrate this into their Pay-by-Text solution.

For more information, visit the company’s website at www.SinglePoint.com

Let us hear your thoughts: SinglePoint, Inc. Message Board

FORM Holdings (NASDAQ: FH) employs a relatively simple yet extremely robust targeting matrix when it comes to acquiring new development candidates. It’s really all about what this diverse holding company can bring to table, as well as how much an otherwise promising, vetted target can benefit – whether it is additional capital and restructuring we are talking about, or full-scale rebranding and implementation of new best practice procedures. Similarly, candidates are selected that can clearly benefit from the kind of new talent recruitment, as well as tailored marketing, public relations, and visibility enhancement, that only an outfit of FORM Holdings’ caliber can provide.

The operational profile of FORM Holdings spans several wholly-owned operating units in technology, including built-to-order, rugged, field-ready mobile and computing products company, Group Mobile; the designer, developer and manufacturer of mobile device-agnostic, wire-free rapid charging and power systems, FLI Charge; and an IP monetization company, Vringo, which works a growing portfolio with more than 75 technology patents, covering everything from telecom infrastructure, remote monitoring and internet search, to ad-insertion, wireless charging, and mobile technologies. The Company also maintains an 8.5 percent stake in Infomedia, a privately-owned, leading UK-based CRM (customer relationship management) and monetization tech provider to mobile carriers and device manufacturers.

However, FORM Holdings has shifted a good deal of its overall corporate focus in recent quarters to its newly-acquired health and wellness subsidiary, XpresSpa. For, as CEO and Director Andrew Perlman recently pointed out in an interview with Bloomberg Market’s Pimm Fox, airport traffic in the U.S. was up 3.2 percent to 929 million passengers last year alone, according to the latest data from the Bureau of Transportation Statistics. XpresSpa represented approximately 70 percent of FORM Holdings’ 2016 revenues, whereas the aforementioned other four business units represented only the remaining 30 percent. XpresSpa raked in some $43.6 million last year, with hearty store level profitability margins of around 20 percent.

Unlike traditional brick and mortar retail that has seen increasingly dramatic erosion by e-commerce (as antiquated and vulnerable operations become displaced by digital commerce of some form or another), airport terminals provide a comparatively captive consumer audience that is willing to spend more for immediate satisfaction. This only becomes more and more the norm in a world where enhanced security procedures often mean longer wait times and increased stress. Indeed, checkpoint traffic rose 15 percent from 2011 to 2016, while the number of screeners declined roughly 5.5 percent. Even with TSA PreCheck, more travelers and fewer screeners has led to long wait lines and grumpy passengers.

According to the Department of Transportation, consumer complaints from all categories against airlines were up 47 percent from 2014 to 2015, and they rose another 10 percent last year. With a variety of well-publicized stories in the news recently about airline carriers failing to live up to customers’ service expectations, the welcoming promise of a pre- or post-flight XpresSpa decompression session may be just the ticket when it comes to encouraging travelers to keep flying the not-always-so-friendly skies. One look at the full-service spa offerings available – from massage, manicure/pedicure, facials, and waxing, to hair and grooming, as well as shower facilities at some locations – and even the lay investor can see why the XpresSpa business model has caught fire with travelers. This is especially true when one considers the demographic of U.S. air travelers, who have as much as double the median household income, or that of the frequent fliers, who generally have more than double the median household income and make most of their airport retail purchases on impulse due to the same factors which plague all airline travelers, such as boredom, stress, and the hectic nature of most airports.

XpresSpa is more than just a well-recognized and trusted brand that consumers have come to rely on to de-stress before or after a wearying journey. It is also the dominant player in the industry domestically with 3.3 times as many locations in the U.S. market as its next closest competitor, Be Relax, and more locations than all of its competitors combined if we look at total global market saturation (U.S. included). This is an interesting metric indeed, given that the company’s international footprint currently consists of just three stores in Amsterdam and one in Dubai. If we look at the choice CAPEX to profitability data on the Company’s new kiosks, which pulled on average about half the $1 million in sales last year that the in-line stores did, the expansion potential for this sector front-runner becomes even more tantalizing.

While XpresSpa is likely the most recognized and popular airport spa brand among travelers today, with 53 locations in 40 terminals at 22 airports, one of the real keys to building the company’s presence has been to deploy multiple locations at a single airport. For instance, the Company has seven stores and a kiosk at New York’s JFK alone, which was actually the number one large U.S. hub last year for international enplanements, and was the fifth busiest U.S. air travel hub (by total boarding).

Just to underscore the viability of this multiple location per venue model, and to dissuade investors from the notion that eight is enough when it comes to venue saturation, the company has another location slated to open at JFK in Q2 FY17. It says a lot about the business model’s expansion potential to see XpresSpa going for a ninth location at JFK (3.4 percent increase last year to nearly 28.9 million passengers), and the Company has three more locations slated for this year as well, which will make seven total new locations opened in all since the acquisition of XpresSpa was announced by FORM Holdings back in August of 2016.

Another key to the success and overall profitability of the XpresSpa model has been a superb and growing selection of retail items ranging from high-quality but affordable grab-and-go travel accoutrements, like best seller $18.00 travel pillows and $10.00 satin eye masks, to the $180.00 luxurious cashmere travel set, which includes a 100 percent silk eye mask, in addition to the 100 percent cashmere blanket, pillow, and mask cover case. Beyond travel blankets, masks and pillows, XpresSpa sells a wide variety of other spa products, including bath & body, hair and personal care items, hydrogel eye and face masks to revitalize tissues, and therapeutic massagers. The global airport retail market is on pace to hit $90 billion by 2023 according to a new report from Credence Research, and the U.S. space alone was estimated at around $4.5 billion back in 2015 by Micro Market Monitor.

Add to XpresSpa’s established store/product driven brand presence with the May 8 announcement of an exclusive partnership with hot, on-trend private label and branded product designer/manufacturer Capelli New York, and you have the formula for retail dynamite. Capelli has serious traction in the coveted junior and contemporary markets, with coordinated product lines in the fashion accessory and jewelry segments, as well as in hosiery, footwear, sleepwear, and home fashion (among others). The move to have Capelli co-produce and sell XpresSpa’s branded travel, spa products and accessories is something which should translate handily into expanded reach, brand presence, and overall gross margins. On this subject, it is worth pointing out to investors that XpresSpa is helmed by the former VP of premium, luxury and sports eyewear brand Luxottica, Ed Jankowski, who was also formerly Senior VP for gourmet Belgian chocolatier Godiva. This is a company that understands how to connect with high earners through premium offerings.

Furthermore, FORM Holdings has some big overhauls coming this year for XpresSpa, including XpresSpa 2.0 locations with improved aesthetics, layout, efficiency optimizations, and service offerings. Additionally, a new POS system (slated for Q4) will be fully integrated with the reservation system, open up expanded digital marketing capabilities, and leverage an already-signed user base of over 140,000 affinity members.

The other 30 percent of 2016 revenues is nothing to sneeze at either. Group Mobile has a solid pipeline of request for proposals with law enforcement, and an emphasis on long term corporate/municipality contracts for its rugged computing options, which are well-served by an experienced sales team who knows the prevailing hardware landscape like the back of its hand. Group Mobile saw 25 percent year over year sales growth last year to $6.6 million, even as bookings and customer commitments increased 128 percent to $12.1 million. Group Mobile serves a wide range of clients, from military and first responders to large select customers such as Macy’s. Rugged laptops, tablets and handhelds, as well as its wide range of other solutions, from body cameras to drones, are just a taste of the thousands of products from top brands that allow Group Mobile to tap an increasingly large slice of the $5 billion and growing domestic rugged mobile computing market.

FLI Charge also deserves a closer look, as it has some of the most advanced/efficient wire-free conductive technology available today. The sheer adaptability of this technology when it comes to working with essentially any battery-powered/DC device on the market today is enough to make FLI Charge worth further investigation on its own – but the usage characteristics of this technology are the real head-turners. Able to deliver wattage via a protocol that is as safe as plugging into a wall outlet, FLI Charge enablements can be embedded easily into any battery operated or DC-powered device, allowing them to be charged or powered via a pad such as the FLIway 40. This same ease of use becomes available for iPhone and Samsung Galaxy phones with FLI Charge’s FLIcases (70 percent thinner than extra battery packs), which remove the need for an enablement and allow the phone to be FLI Charged by simply setting it on the pad in any direction.

Investors can get a good look at FORM Holdings at the upcoming Oppenheimer Emerging Growth Conference, which will be held at the luxurious InterContinental Barclay Hotel in New York City next week. CEO Perlman will be available for one-on-one meetings throughout the day for those who arrange a meeting with Oppenheimer & Co. Inc.

To take a closer look, visit http://www.formholdings.com/corp_overview

Addiction is a widespread crisis in the United States that doesn’t seem to have an end in sight. Both youth and adults suffer the devastating consequences of drug and alcohol addiction, and lives are lost and families are torn apart every day due to its destructive effects. In 2015 alone, more than 50,000 deaths resulted from drug overdoses in the U.S. (http://dtn.fm/2IdEz), but one company is offering new hope to millions of addicted individuals and their loved ones and making major strides to help turn the tide in America’s addiction epidemic.

BioCorRx Inc. (OTCQB: BICX) is an addiction treatment company engaged in developing and providing cutting-edge solutions to treat alcohol and opioid addictions. The company has pioneered a fresh approach to addiction treatment, offering a non-addictive, medication-assisted treatment (MAT) program that consists of two main parts: an outpatient implant procedure performed by a licensed physician and a specially tailored one-on-one counseling program.

The first component of the BioCorRx Recovery Program involves the insertion of an implant that delivers naltrexone to addiction patients. Naltrexone is a non-addictive opioid antagonist that is able to significantly reduce an individual’s physical cravings for opioids and alcohol. The presence of the implant and its ongoing delivery of naltrexone make part two of the BioCorRx Recovery Program possible: one-on-one counseling that is specifically designed to treat the substance abuse addictions of patients receiving long-term naltrexone treatment. Because their addiction cravings have been quelled by the naltrexone, patients are able to make greater progress in psychosocial treatment and can more effectively address the underlying issues driving their addictive behaviors. The result is a much greater chance for patients to achieve long-term sobriety.

BioCorRx CEO Brady Granier recently discussed this revolutionary new treatment program on FOX News (http://dtn.fm/aWB4K) and FOX Business (http://dtn.fm/jZg1Z), detailing the BioCorRx program and the success it is having among patients. Granier also discussed an injectable naltrexone option the company currently has in preclinical development. Through BioCorRx Pharmaceuticals, an R&D subsidiary of BioCorRx, the company is developing, in partnership with TheraKine LTD, a new injection delivery technology for naltrexone called BICX101. This injectable naltrexone offers an additional naltrexone delivery option for addicted individuals in treatment.

BioCorRx also recently announced it has entered into an agreement with DynamiCare Health, Inc. to develop a co-branded mobile application, called DynamiCare Rewards™, with BioCorRx CBT that supports patients who are in treatment for addiction. This app will provide patients with a self-guided, interactive version of the BioCorRx Recovery Program and will enable counselors to remotely monitor their patients’ progress as patients complete the 35 modules of the program.

The tremendous success of BioCorRx’s twofold addiction treatment program—addressing both the physical and psychological aspects of opioid and alcohol addiction—is offering fresh hope for addicted individuals and their loved ones throughout the country.

For more information, visit the company’s website at www.BioCorRx.com

For nearly two decades, ChineseInvestors.com (OTCQB: CIIX) has delivered a wide range of products, information, and services, including several subscription-based services, for the global Chinese speaking population. The specialized investment services company provides real-time market commentary, analysis, and education-related information in the Chinese language, as well as offering consultation, advertising, and public relations services.

The company’s product diversity is a result of its growth-focused, long term quest for value-add opportunities. Not satisfied with a 100,000+ user base, a recognizable 18-year-old brand, and a target market in excess of two billion Chinese speaking people, ChineseInvestors.com recently executed a first-to-market milestone by creating the world’s only Chinese language, cannabinoid-based, therapeutic health products online store, http://www.ChineseCBDoil.com.

After profiting from a successful investment in the marijuana market, the company recognized an immense opportunity and recently expanded into retail and online sales of cannabidiol (CBD) products. With an annual growth rate of nearly 60 percent, CBD oil has become one of the fastest growing market categories in the country, and U.S.-based ChineseInvestors.com aims to capitalize on this meteoric growth by marketing holistic CBD-based products to the more than two billion Chinese speaking people in the world.

CBD oil is considered to have a broad range of medical benefits, and it is non-psychoactive with low-THC and high-CBD content. CBD has shown varying degrees of efficacy in treating epilepsy, Alzheimer’s disease, cirrhosis, pain, anxiety and stress. Given the wide ranging practice of holistic-based Eastern medicine, acceptance and use of CBD oils is not only a natural adjunct, but also an enormous potential revenue generator for ChineseInvestors.com, which suggests that online sales and future retail outlets could easily exceed expectations. All told, ChineseInvestors.com presents an interesting opportunity to profit from the meteoric rise of the medical marijuana market as it relates to a global population of more than two billion Chinese consumers.

For more information, visit the company’s website at www.ChineseInvestors.com

Let us hear your thoughts: ChineseInvestors.com, Inc. Message Board

Precision medicine and precision diagnostics in particular play a major role in today’s medical world, by helping patients and physicians detect various diseases in time, which in turn allows for the proper treatments and care to be prescribed. Companies such as Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) are at the forefront of precision medicine, developing innovative immunodiagnostics and immunotherapeutic platforms that can make a real difference for patients suffering from serious ailments such as cancer or infectious, autoimmune or inflammatory diseases.

A leader in precision medicine via the development and commercialization of precision diagnostics and therapeutics based on immune system functions, Ohio-based biopharma company Navidea is working on multiple products built around its proprietary Manocept™ platform. The platform is based on the ability to target macrophages – a type of white cells essential to immune systems, whose main role is to detect microscopic foreign bodies or substances and eat them, for the detection, monitoring and treatment of specific diseases. Manocept™ is able to specifically target the CD206 mannose receptor present in targeted macrophages, allowing for enhanced flexibility and versatility and, ultimately, leading to increased diagnostic accuracy and improved targeted treatment and patient care.

The platform is at the core of Navidea’s flagship product, Lymphoseek®, a state-of-the-art, receptor-targeted radiopharmaceutical agent used for the mapping of lymphatic basis or the biopsy of sentinel lymph nodes in patients with different types of cancers. Administered as an injection of technetium Tc 99m tilmanocept, Lymphoseek® has been successfully used for diagnostics in patients with clinically node negative breast cancer, squamous cell carcinoma of the oral cavity or melanoma.

Lymphoseek® has been approved by the U.S. Food and Drug Administration and has been in use nationwide since its launch in 2013. Recently, Navidea sold American rights to the diagnostic tool to Cardinal Health Inc. (NYSE: CAH) for a guaranteed $100 million in payments over the next three years (http://dtn.fm/32PpG). The sale’s value could rise to $310 million throughout the life of the agreement. In addition, Navidea already has European distribution in place for the cancer diagnostic aid and is seeking further commercialization opportunities in the rest of the world.

Aside from Lymphoseek®, the company is looking for other ways to expand the use of its Manocept™ platform, for diagnostics across a wide range of disorders such as rheumatoid arthritis, Crohn’s disease, tuberculosis, Kaposi’s sarcoma and others. Navidea is already looking into expanding the targeted macrophages-based platform diagnostic for many of these disorders, with clinical studies underway for rheumatoid arthritis, cardiovascular disease and more.

Another potential use for the Manocept™ platform is the development of macrophage therapeutics using the Lymphoseek® delivery system. The company is currently working on the development of immunotherapeutics for cancer, inflammatory, autoimmune and infectious diseases and has so far reported encouraging results in preclinical trials, data suggesting several positive drug properties in terms of safety, duration of action, deliverability and costs. Results of animal testing have also indicated clear progress of macrophage therapeutics for various disorders including arthritis, asthma, Nonalcoholic Steatohepatitis-related inflammation, neuro-inflammation and multiple cancers.

For more information about Navidea Biopharmaceuticals and its innovative precision immunodiagnostic tools, visit the company’s website at www.Navidea.com